RXRX - Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism | Benzinga
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) made waves Monday with the announcement of the completion of its groundbreaking BioHive-2 supercomputer, as well as the notable surge in its stock that followed.
RXRX Price Action: Recursion Pharmaceutical shares closed at $9.48 on Monday, reflecting an impressive gain of 10.2% compared to the previous day’s close, according to Benzinga Pro.
What Happened: Recursion’s stock surge came after the company announced the completion of its new Nvidia Corp (NASDAQ:NVDA)-powered AI supercomputer. The computer, called BioHive-2, is powered by 63 Nvidia H100 systems with a total of 504 Nvidia H100 Tensor Core GPUs, interconnected by Nvidia Quantum-2 ...